Researchers based at Aston Medical School, Birmingham, monitored the survival of over a million people who had risk factors for
Category: Survival
Patients immune system and cancer Immunotherapy
Researchers discovered that higher levels of tumor-associate immune cells TAICs expressing programmed death-ligand 1 PD-L1 were linked with longer complete
